Transparency and Accountability in Medicare Bidding Act of 2013

H.R. 942 and S. 948, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013; H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013; H.R. 2375, Transparency and Accountability in Medicare Bidding Act of 2013; H.R. 4920 and S. 2975 Medicare DMEPOS Competitive Bidding Improvement Act

Client expense: $109,572 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 3509: Patient Protection and Affordable Care Act of 2010 - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency HR 3692: The Affordable Health Care for America Act: Imaging cuts, device tax transparency and remote monitoringHR 4695 Medicare OSA Sleep Testing Bill HR 1932 Better Care, Lower Cost Act PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services S 596 - The FITT Act of 2013 (Fostering Independence Through Technology Act) - specifically the telehealth provisions HR 2914 - Imaging self-referral HR 1717 - The Medicare DMEPOS - Marketing Pricing Program Act of 2013 HR 8 - "American Tax Payer Relief Act of 2012" - Medicare Imaging Cuts & Sustainable Growth Rate Extension Site-neutrality in payments (no bill number yet) HR 2375 - The Transparency and Accountability in Medicare Bidding Act of 2013 HR 4015 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria CT Dose Optimization HR 6179 - "The Telehealth Promotion Act of 2012" HR 6626 - "The Health Care Innovation and Marketplace Technologies Act of 2012" - Telemedicine provisions. Drafts in the House and Senate addressing the SGR formula - potential telehealth provisions. HR 4920 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2014 HR 5083 The Medicare DMEPOS Audit Improvement and Reform Act

Client expense: $370,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 942/S. 948- Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013, all provisions; H.R. 1250/S. 1012- Medicare Audit Improvement Act of 2013, all provisions; H.R. 27- Small Supplier Fairness in Bidding Competition Act of 2013, all provisions; H.R. 1717- Medicare DMEPOS Market Pricing Program Act of 2013, all provisions; H.R. 2375- Transparency and Accountability in Medicare Bidding Act of 2013, all provisions; H.R. 2810 - SGR Repeal and Medicare Beneficiary Access Act of 2013, all provisions; S. 1871 - SGR Repeal and Medicare Beneficiary Access Act of 2013, all provisions; H.R. 4302 - Protecting Access to Medicare Act of 2014, all provisions; H.R. 4920/ H.R. 5809/S.2975 Medicare DMEPOS Competitive Bidding Improvement Act of 2014.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned EntitiesIssues relating to remote patient management and telehealth S. 2689 & H.R. 5644 - Medicare CGM Access Act of 2014 - provisions related to continuous glucose monitoring H.R. 5380 - Medicare Telehealth Parity Act of 2014 - provisions that expand definition of telehealth into remote patient monitoring in chronic conditions

Client expense: $1,420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to Round One recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.H.R. 2725 - FDA Safety Over Sequestration Act of 2013, and S. 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration H.R. 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like abdominal aortic aneurysm, hypertension screenings. H.R. 3077 The TELE-MED Act of 2013 provisions related to telemedicine and remote monitoring that increase access to health care and enhance patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of health information technology and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).

Client expense: $1,420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 3509: Patient Protection and Affordable Care Act of 2010 - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency HR 3692: The Affordable Health Care for America Act: Imaging cuts, device tax transparency and remote monitoringHR 4695 Medicare OSA Sleep Testing Bill HR 1932 Better Care, Lower Cost Act PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services S 596 - The FITT Act of 2013 (Fostering Independence Through Technology Act) - specifically the telehealth provisions HR 2914 - Imaging self-referral HR 1717 - The Medicare DMEPOS - Marketing Pricing Program Act of 2013 HR 8 - "American Tax Payer Relief Act of 2012" - Medicare Imaging Cuts & Sustainable Growth Rate Extension Site-neutrality in payments (no bill number yet) HR 2375 - The Transparency and Accountability in Medicare Bidding Act of 2013 HR 4015 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria CT Dose Optimization HR 6179 - "The Telehealth Promotion Act of 2012" HR 6626 - "The Health Care Innovation and Marketplace Technologies Act of 2012" - Telemedicine provisions. Drafts in the House and Senate addressing the SGR formula - potential telehealth provisions. HR 4920 - The Medicare DMEPOS Competitive Bidding Improvement Act of 2014 HR 5083 The Medicare DMEPOS Audit Improvement and Reform Act

Client expense: $350,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues HR.1250/S.1012, Medicare Audit Improvement Act, Medical Device issues H.R.2329, Administrative Relief and Accurate Medicare Payments Act of 2013, Medical device issues H.R.5083, Medicare DMEPOS Audit Improvement and Reform (AIR) Act of 2014, Medical device issues Monitor the following: Public Law 113-93, Protecting Access to Medicare Act of 2014

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 942 and S. 948, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013; H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013; H.R. 2375, Transparency and Accountability in Medicare Bidding Act of 2013; H.R. 4920 Medicare DMEPOS Competitive Bidding Improvement Act

Client expense: $115,439 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 942/S. 948- Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013, all provisions; H.R. 1250/S. 1012- Medicare Audit Improvement Act of 2013, all provisions; H.R. 27- Small Supplier Fairness in Bidding Competition Act of 2013, all provisions; H.R. 1717- Medicare DMEPOS Market Pricing Program Act of 2013, all provisions; H.R. 2375- Transparency and Accountability in Medicare Bidding Act of 2013, all provisions; H.R. 2810 - SGR Repeal and Medicare Beneficiary Access Act of 2013, all provisions; S. 1871 - SGR Repeal and Medicare Beneficiary Access Act of 2013, all provisions; H.R. 4302 - Protecting Access to Medicare Act of 2014, all provisions; H.R. 4920 Medicare DMEPOS Competitive Bidding Improvement Act of 2014.

Client expense: $90,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research

Client expense: $1,580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory Board. S. 351 - Protecting Seniors Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory BoardH.R. 4302 - Protecting Access to Medicare Act of 2014 - provisions related to supporting permanent fix of the sustainable growth rate formula HR 4015 The SGR Repeal & Medicare Provide Payment Modernization Act of 2014 Issues related to amending title XVIII of the Social Security Act to reform the Sustainable Growth Rate (SGR) formula use in the Medicare Physician Fee Schedule Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 H. Con. Res. 25, S. Con. Res. 8, P.L. 112-240 American Taxpayer Relief Act of 2012 and P.L. 113-6 - Consolidated and Further Continuing Appropriations Act 2013 - provisions related to HHS funding, including Medicare reimbursement Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities

Client expense: $1,580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 942/S. 948- Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013, all provisions; H.R. 1250/S. 1012- Medicare Audit Improvement Act of 2013, all provisions; H.R. 27- Small Supplier Fairness in Bidding Competition Act of 2013, all provisions;H.R. 1717- Medicare DMEPOS Market Pricing Program Act of 2013, all provisions; H.R. 2375- Transparency and Accountability in Medicare Bidding Act of 2013, all provisions; H.R. 2810 - SGR Repeal and Medicare Beneficiary Access Act of 2013, all provisions; S. 1871 - SGR Repeal and Medicare Beneficiary Access Act of 2013, all provisions; H.R. 4302 - Protecting Access to Medicare Act of 2014, all provisions; H.R. 4920 Medicare DMEPOS Competitive Bidding Improvement Act of 2014.

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).

Client expense: $1,360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities

Client expense: $1,360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 3509: Patient Protection and Affordable Care Act of 2010 - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency HR 3692: The Affordable Health Care for America Act: Imaging cuts, device tax transparency and remote monitoringHR 4695 Medicare OSA Sleep Testing Bill HR 1932 Better Care, Lower Cost Act PL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services S 596 - The FITT Act of 2013 (Fostering Independence Through Technology Act) - specifically the telehealth provisions HR 2914 - Imaging self-referral HR 1717 - The Medicare DMEPOS - Marketing Pricing Program Act of 2013 HR 8 - "American Tax Payer Relief Act of 2012" - Medicare Imaging Cuts & Sustainable Growth Rate Extension Site-neutrality in payments (no bill number yet) HR 2375 - The Transparency and Accountability in Medicare Bidding Act of 2013 HR 4015 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria CT Dose Optimization HR 6179 - "The Telehealth Promotion Act of 2012" HR 6626 - "The Health Care Innovation and Marketplace Technologies Act of 2012" - Telemedicine provisions. Drafts in the House and Senate addressing the SGR formula - potential telehealth provisions.

Client expense: $380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues HR.1250/S.1012, Medicare Audit Improvement Act, Medical Device issues H.R.2329, Administrative Relief and Accurate Medicare Payments Act of 2013, Medical device issues Monitor the following: Public Law 113-93, Protecting Access to Medicare Act of 2014

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 942/S. 948- Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013, all provisions; H.R. 1250/S. 1012- Medicare Audit Improvement Act of 2013, all provisions; H.R. 27- Small Supplier Fairness in Bidding Competition Act of 2013, all provisions;H.R. 1717- Medicare DMEPOS Market Pricing Program Act of 2013, all provisions; H.R. 2375- Transparency and Accountability in Medicare Bidding Act of 2013, all provisions; H.R. 2810 - SGR Repeal and Medicare Beneficiary Access Act of 2013, all provisions; S. 1871 - SGR Repeal and Medicare Beneficiary Access Act of 2013, all provisions; H.R. 4302 - Protecting Access to Medicare Act of 2014, all provisions; H.R. 4920 Medicare DMEPOS Competitive Bidding Improvement Act of 2014.

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R. 942 and S. 948, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013; H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013; H.R. 2375, Transparency and Accountability in Medicare Bidding Act of 2013; H.R. 4920 Medicare DMEPOS Competitive Bidding Improvement Act

Client expense: $151,710 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues HR.1250/S.1012, Medicare Audit Improvement Act, Medical Device issues H.R.2329, Administrative Relief and Accurate Medicare Payments Act of 2013, Medical device issues Monitor the following: S.1871, SGR Repeal and Medicare Beneficiary Access Act of 2013 H.R.4302, Protecting Access to Medicare Act of 2014 H.R.2810, Medicare Patient Access and Quality Improvement Act of 2013

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - HR 2375, "Competitive Bidding for DME Delay", regarding all provisions. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - HR 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014", regarding all provisions. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing.

Client expense: $2,110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Policy issues relating to competitive bidding for durable medical equipment, including H.R. 1717, the "Medicare DMEPOS Market Pricing Program Act" and H.R.2375, the "Transparency and Accountability in Medicare Bidding Act."

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageH.R. 27, Small Supplier Fairness in Bidding Competition Act of 2013, competitive bidding H.R. 2375, Transparency and Accountability in Medicare Bidding Act of 2013 ***, no specific bill(s), Medicare Inhalation Drug Therapies and Oxygen Reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity, National Provider Identification Number

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues HR.1250/S.1012, Medicare Audit Improvement Act, Medical Device issues H.R.2329, Administrative Relief and Accurate Medicare Payments Act of 2013, Medical device issues Monitor the following: S.1871, SGR Repeal and Medicare Beneficiary Access Act of 2013 H.R.4302, Protecting Access to Medicare Act of 2014 H.R.2810, Medicare Patient Access and Quality Improvement Act of 2013

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory Board. S. 351 - Protecting Seniors Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory BoardH.R. 4302 - Protecting Access to Medicare Act of 2014 - provisions related to supporting permanent fix of the sustainable growth rate formula HR 4015 The SGR Repeal & Medicare Provide Payment Modernization Act of 2014 Issues related to amending title XVIII of the Social Security Act to reform the Sustainable Growth Rate (SGR) formula use in the Medicare Physician Fee Schedule Issues related to continuous glucose monitoring Issues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 H. Con. Res. 25, S. Con. Res. 8, P.L. 112-240 American Taxpayer Relief Act of 2012 and P.L. 113-6 - Consolidated and Further Continuing Appropriations Act 2013 - provisions related to HHS funding, including Medicare reimbursement Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities

Client expense: $1,480,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research

Client expense: $1,480,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 3509: Patient Protection and Affordable Care Act of 2010 - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency HR 3692: The Affordable Health Care for America Act: Imaging cuts, device tax transparency and remote monitoringPL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services S. 596 - The FITT Act of 2013 (Fostering Independence Through Technology Act) - specifically the telehealth provisions HR 2914 - Imaging self-referral HR 1717 - The Medicare DMEPOS - Marketing Pricing Program Act of 2013 HR 8 - "American Tax Payer Relief Act of 2012" - Medicare Imaging Cuts & Sustainable Growth Rate Extension Site-neutrality in payments (no bill number yet) HR 2375 - The Transparency and Accountability in Medicare Bidding Act of 2013 HR 4015 - Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria CT Dose Optimization HR 6179 - "The Telehealth Promotion Act of 2012" HR 6626 - "The Health Care Innovation and Marketplace Technologies Act of 2012" - Telemedicine provisions. Drafts in the House and Senate addressing the SGR formula - potential telehealth provisions.

Client expense: $640,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

H.R. 942 and S. 948, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013; H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013; H.R. 2375, Transparency and Accountability in Medicare Bidding Act of 2013

Client expense: $197,069 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; H.R. 942/S. 948- Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013, all provisions; H.R. 1250/ S. 1012- Medicare Audit Improvement Act of 2013, all provisions; H.R. 27- Small Supplier Fairness in Bidding Competition Act of 2013, all provisions;H.R. 1717- Medicare DMEPOS Market Pricing Program Act of 2013, all provisions; H.R. 2375- Transparency and Accountability in Medicare Bidding Act of 2013, all provisions; H.R. 2810 - Medicare Patient Access and Quality Act of 2013, all provisions; S. 1871 - The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013, all provisions; H.R. 4302- Protecting Access to Medicare Act of 2014, all provisions.

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, competitive rates for Medicaid bidding and fraud abuse; H.R. 942/S. 948, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013, all provisions; H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013, all provisions; (see contination page)H.R 27, Small Supplier Fairness in Building Competition Act of 2013, all provisions. H.R. 1717, Medicare DEMPOS Market Pricing Program Act of 2013, all provisions. H.R. 2375, Transparency and Accountability in Medicare Bidding, Act of 2013, all provisions. H.R. 2810, Medicare Patient Access and Quality Act of 2013, all provisions. S. 1871, The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013, all provisions. H.R. 4302, Protecting Access to Medicare Act of 2014, all provisions.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete. HR 2810 - the Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of SGR HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestrationHR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to remote monitoring that increase access to health care H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile applications Issues related to neuroscience research

Client expense: $1,130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory Board. S. 351 - Protecting Seniors Access to Medicare Act of 2013 - provisions related to the repeal of the Medicare Independent Payment Advisory BoardIssues related to competitive bidding for DME products including HR 2375 - the Transparency and Accountability in Medicare Bidding Act of 2013 Issues related to Medicare coverage of continuous glucose monitoring devices H. Con. Res. 25, S. Con. Res. 8, P.L. 112-240 American Taxpayer Relief Act of 2012 and P.L. 113-6 - Consolidated and Further Continuing Appropriations Act 2013 - provisions related to HHS funding, including Medicare reimbursement Issues related to amending title XVIII of the Social Security Act to reform the Sustainable Growth Rate (SGR) formula use in the Medicare Physician Fee Schedule Issues related to HHS office of Inspector General (OIG) and Senate Finance Committee investigations of Physician-Owned Entities

Client expense: $1,130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - HR 2375, "Competitive Bidding for DME Delay", regarding all provisions. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - S. 1871, "SGR Repeal and Medicare Beneficiary Access Act of 2013", regarding all provisions. - Issues related to health care associated infections. - S. 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions.

Client expense: $860,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

**see addendum pageH.R. 27, Small Supplier Fairness in Bidding Competition Act of 2013, competitive bidding H.R. 2375, Transparency and Accountability in Medicare Bidding Act of 2013 ***, no specific bill(s), Medicare Inhalation Drug Therapies and Oxygen Reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity, National Provider Identification Number

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 3509: Patient Protection and Affordable Care Act of 2010 - various provisions including: Medical Device Excise Tax, various reimbursement cuts and policy proposals for medical imaging; remote monitoring technology in the context of accountable care organizations, medical homes and post acute bundling; transparency HR 3692: The Affordable Health Care for America Act: Imaging cuts, device tax transparency and remote monitoringPL 110-275: "Medicare Improvements for Patient and Providers Act" (sec. 135) - Medical imaging accreditations program; medical imaging clinical appropriateness demonstration program Decline in growth rate of Medicare non-hospital imaging services S. 596 - The FITT Act of 2013 (Fostering Independence Through Technology Act) - specifically the telehealth provisions HR 2914 - Imaging self-referral HR 1717 - The Medicare DMEPOS - Marketing Pricing Program Act of 2013 HR 8 - "American Tax Payer Relief Act of 2012" - Medicare Imaging Cuts & Sustainable Growth Rate Extension Site-neutrality in payments (no bill number yet) MR / CT cost center change (no bill number yet) HR 2375 - The Transparency and Accountability in Medicare Bidding Act of 2013 Long-term Sustainable Growth Rate (SGR) replacement legislation Appropriate Use Criteria CT Dose Optimization CMS Maintenance Directive revision HR 6179 - "The Telehealth Promotion Act of 2012" HR 6626 - "The Health Care Innovation and Marketplace Technologies Act of 2012" - Telemedicine provisions. Drafts in the House and Senate addressing the SGR formula - potential telehealth provisions.

Client expense: $320,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013, Competitive bidding program and makret pricing issues for Durable Medical Equipment (DME) H.R.2375, Transparency and Accountability in Medicare Bidding Act of 2013, Issues related to Medical Device issues Monitor the following: The Sustainable Growth Rate (SGR) Repeal and Medicare Beneficiary Access Improvement Act of 2013 H.R.2810, Medicare Patient Access & Quality Improvement Act of 2013

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including: bidding, power wheelchairs, oxygen, diabetic supplies, negative pressure wound therapy, Medicare audits, sequestration, and fraud abuse; Tax Reform Act of 2013, all provisions; H.R. 942/S. 948, Ensuring Access to Quality Complex Rehabilitation Act of 2013, all provisions; H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013, all provisions; (see contination page)H.R 27, Small Supplier Fairness in Building Competition Act of 2013, all provisions. H.R. 1717, Medicare DEMPOS Market Pricing Program Act of 2013, all provisions. H.R. 2375, Transparency and Accountability in Medicare Bidding, Act of 2013, all provisions. H.R. 2810, Medicare Patient Access and Quality Act of 2013, all provisions. S. 1871, The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013, all provisions.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2375- Transparency and Accountability in Medicare Bidding Act of 2013; Fairness for Small Pharmacies in Preferred Networks; Repeal of National Mail Order Program for Diabetes Testing Supplies Home Delivery; S.644- The Preventing Abuse of Cough Treatments Act of 2013; H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug;S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; TRICARE Pharmacy Benefit/Provisions; Medicaid Reimbursment Cuts; PBM audit and generic pricing reform

Client expense: $380,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE

Policy issues relating to competitive bidding for durable medical equipment, including H.R. 1717, the "Medicare DMEPOS Market Pricing Program Act" and H.R.2375, the "Transparency and Accountability in Medicare Bidding Act."

Client expense: Not reported · Firm income: $30,000

Government targets: SENATE

H.R. 942 and S. 948, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013; H.R.1717, Medicare DMEPOS Market Pricing Program Act of 2013; H.R. 2375, Transparency and Accountability in Medicare Bidding Act of 2013

Client expense: $116,434 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE